[Remarks on toxoplasmosis therapy based on indications].
D004359:Drug Therapy, Combination; D005260:Female; D006790:Host-Parasite Interactions; D006801:Humans; D011247:Pregnancy; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000188:drug therapy* / Q000469:parasitology
D013411:Sulfadiazine; D011739:Pyrimethamine
Bemerkungen zur indikationsgerechten Toxoplasmosetherapie.